COVID vaccine applications for commercial distribution possible by 2021: FDA

ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="http://sa.kapamilya.com/absnews/abscbnnews/media/2021/news/05/06/20210504-vaccine-sputnikv-1.jpg"/><figcaption>Medical workers receive their first dose of the Sputnik V COVID-19 vaccine at the Sta. Ana Hospital in Manila on May 4, 2021, as the Russian vaccine rolls out in five cities in Metro Manila. <em>Mark Demayo, ABS-CBN News</em></figcaption></figure></div><p>MANILA - Applications for the commercial distribution of COVID-19 vaccines could come as early as next year, the Food and Drug Administration said Thursday.</p><p>The Philippines has so far only granted emergency use authorization (EUA) to vaccine candidates of 7 drugmakers: Pfizer-BioNTech, Oxford-AstraZeneca, Gamaleya Institute, Sinovac Biotech, Johnson &amp; Johnson, and Bharat Biotech, and Moderna.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/05/05/21/fda-approves-emergency-use-of-modernas-covid-19-vaccine">FDA approves emergency use of Moderna&#x27;s COVID-19 vaccine</a></li></ul><p>&quot;Before you get a certificate of product registration (CPR) you have to complete your phase 3 trial. Personally I expect the earliest mag a-apply for CPR is late this year or early next year,&quot; FDA director-general Eric Domingo told ANC&#x27;s Headstart.</p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1678990" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/12/10/20/which-covid-19-vaccine-is-most-cost-friendly-for-ph-government">Which COVID-19 vaccine is most cost-friendly for PH government?</a></li></ul><p>The agency had also granted compassionate special permit (CSP) for the use of Sinopharm&#x27;s COVID-19 jab on President Rodrigo Duterte&#x27;s close-in security detail.</p><p>Duterte earlier this week was vaccinated with the Chinese vaccine, which he has since ordered to be pulled out of the country, Domingo said.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/05/05/21/duterte-sinopharm-vaccinated-covid">Duterte on his Sinopharm COVID-19 jab: &#x27;This is my life&#x27;</a></li>	<li><a href="https://news.abs-cbn.com/news/05/06/21/duterte-sinopharm-sinovac-china">Duterte to Chinese envoy: Send us Sinovac COVID-19 shots, not Sinopharm</a></li></ul><p>&quot;The President accepted there was a lapse. Pinatanggal niya na lahat ng Sinopharm na nandito sa Pilipinas,&quot; he said.</p><p>(He has ordered the removal of all Sinopharm vaccines here in the Philippines.)</p><p>&quot;I think yesterday we were very successfully able to explain to the President the situation. And as you can see the President is maybe willing to rectify once he realize there was a problem using a vaccine that is under CSP instead of using a vaccine under EUA.&quot;</p><p>The FDA has asked the Presidential Security Group to submit a report on how many doses were brought in the country, how many were used, the list of persons inoculated, and side effects or outcomes monitored, Domingo said.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/05/04/21/fda-sinopharm-covid-19-vaccine-duterte">&#x27;Hindi pa napag-aralan&#x27;: FDA has not yet evaluated Chinese COVID-19 jab used on Duterte</a></li></ul><p>The Philippines is aiming to inoculate 50 to 70 million of its population against COVID-19 by yearend to achieve herd immunity. As of Tuesday, it has administered 2.065 million doses of COVID-19 vaccine.</p><div class="infogram-embed" data-id="_/yFVE69R1WlSdqY3aCsBF" data-title="COVID-19 VACCINE TRACKER PH" data-type="interactive"> </div><script type="text/javascript">!function(e,i,n,s){var t='InfogramEmbeds',d=e.getElementsByTagName('script')[0];if(window[t]&&window[t].initialized)window[t].process&&window[t].process();else if(!e.getElementById(n)){var o=e.createElement('script');o.async=1,o.id=n,o.src='https://e.infogram.com/js/dist/embed-loader-min.js',d.parentNode.insertBefore(o,d)}}(document,0,'infogram-async');</script>

<p>MANILA - Applications for the commercial distribution of COVID-19 vaccines could come early next year, the Food and Drug Administration said Thursday.<br /> </p>

MANILA - Applications for the commercial distribution of COVID-19 vaccines could come early next year, the Food and Drug Administration said Thursday.

COVID vaccine applications for commercial distribution possible by 2021: FDA | ABS-CBN

Entertainment

News

Metro.Style

Sports

More

News

COVID vaccine applications for commercial distribution possible by 2021: FDA

COVID vaccine applications for commercial distribution possible by 2021: FDA

ABS-CBN News

Published May 06, 2021 11:47 AM PHT

|

Updated May 06, 2021 12:01 PM PHT

Read More:

ANC

ANC Top

ANC Exclusives

Headstart

FDA

Food and Drug Administration

Eric Domingo

COVID-19 vaccine

Philippines COVID-19 vaccination

COVID-19

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Advertise with Us

Privacy Policy

Terms of Service

© 2025 ABS-CBN Corporation. All Rights Reserved.